These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4817085)

  • 1. Antidiuretic responses to hypertonic saline infusion, water deprivation, and a synthetic analogue of vasopressin in patients with hereditary, hypothalamic diabetes insipidus.
    Andersson KE; Arner B; Fürst E; Hedner P
    Acta Med Scand; 1974; 195(1-2):17-23. PubMed ID: 4817085
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
    Aronson AS; Andersson KE; Bergstrand CG; Mulder JL
    Acta Paediatr Scand; 1973 Mar; 62(2):133-40. PubMed ID: 4691456
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with new synthetic analogue of vasopressin in diabetes insipidus.
    Nash H
    Arch Dis Child; 1973 Dec; 48(12):979-80. PubMed ID: 4765662
    [No Abstract]   [Full Text] [Related]  

  • 4. A vasopressin analogue in treatment of diabetes insipidus.
    Kauli R; Laron Z
    Arch Dis Child; 1974 Jun; 49(6):482-5. PubMed ID: 4850356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years. (Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide).
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 55(5):359-65. PubMed ID: 5439569
    [No Abstract]   [Full Text] [Related]  

  • 6. Diuretic and antidiuretic effects of furosemide before and during the early period of pitressin therapy in diabetes insipidus.
    Radó JP; Takó J; Szabó T; Bános C
    Endokrinologie; 1969; 54(1):26-35. PubMed ID: 5358572
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of diabetes insipidus with carbamazepine.
    Wales JK
    Lancet; 1975 Nov; 2(7942):948-51. PubMed ID: 53432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of exogenous 3':5'-adenosine monophosphate on urinary output in children with vasopressin-resistant diabetes insipidus.
    Proesmans W; Eggermont E; Vanderschueren-Lodeweyckx M; Tiddens H; Eeckels R
    Pediatr Res; 1975 May; 9(5):509-12. PubMed ID: 166349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary vasopressin-resistant diabetes insipidus in SWV mice.
    Virgo NS; Miller JR
    Can J Physiol Pharmacol; 1974 Oct; 52(5):995-1011. PubMed ID: 4426000
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioimmunoassay of vasopressin in familial cental diabetes insipidus.
    Kaplowitz PB; D'Ercole AJ; Robertson GL
    J Pediatr; 1982 Jan; 100(1):76-81. PubMed ID: 7057320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited forms of diabetes insipidus and diagnostic drug applications.
    Relkin R
    Ann N Y Acad Sci; 1968 Jul; 151(2):880-6. PubMed ID: 5263695
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trial of a vasopressin analog, DDAVP, in 4 patients with diabetes insipidus].
    Borner W; Froesch ER
    Schweiz Med Wochenschr; 1974 Apr; 104(16):579-82. PubMed ID: 4827026
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies.
    Edwards CR; Kitau MJ; Chard T; Besser GM
    Br Med J; 1973 Aug; 3(5876):375-8. PubMed ID: 4581079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the hypertonic saline serum test and vasopressin determination for the differential diagnosis of diabetes insipidus].
    Martínez Vea A; Calderón MD; Camps J; Rivera F; Vilardell E; Revert L
    Med Clin (Barc); 1984 Jun; 83(2):54-7. PubMed ID: 6471945
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy.
    Vokes TJ; Gaskill MB; Robertson GL
    Ann Intern Med; 1988 Feb; 108(2):190-5. PubMed ID: 3341651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of diabetes insipidus with 1-desamino-8-D-arginine-vasopressin (author's transl)].
    Irmscher K; Sennejunker K; Wiegelmann W; Solbach HG
    Dtsch Med Wochenschr; 1974 Nov; 99(48):2431-7. PubMed ID: 4614967
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Powdered lysine-vasopressin (vasopressin spray) in the treatment of diabetes insipidus].
    Tamas G; CHATEL R
    Orv Hetil; 1975 Jan; 116(4):191-4. PubMed ID: 1110833
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous vasopressin replacement in diabetes insipidus.
    Ralston C; Butt W
    Arch Dis Child; 1990 Aug; 65(8):896-7. PubMed ID: 2400231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.